These two ingredients work alongside Eflornithine in HairlessHype, each contributing through a different mechanism. Together, they make the combination more effective than Eflornithine alone for many women.
Metformin. Best known as an oral insulin-sensitizing medication, but topical Metformin has documented effects in the skin itself:
- Mild anti-androgen effect at the local level. Metformin can reduce local androgen activity in the skin, which is one of the underlying drivers of unwanted facial hair in PCOS. The systemic anti-androgen effect of Metformin is also relevant for women taking it orally — see the Insulin Sensitizers section for that picture.
- Anti-inflammatory effect. Reduces inflammation in the skin where it's applied — relevant because PCOS-pattern hirsutism often comes with inflammatory skin changes around the affected follicles.
- Influences cell turnover. Slows certain types of cell growth, which complements Eflornithine's effect on hair follicle activity.
Azelaic Acid. A well-studied skincare ingredient with several relevant effects.
- Slows keratin production in the hair follicle, which can weaken the structure of new hairs as they grow in. The result is finer, less coarse hair over time.
- Reduces inflammation in the skin, similar to Metformin's effect but through a different pathway. The two ingredients are complementary, not redundant.
- Evens skin tone. Helps fade post-inflammatory pigmentation that often accumulates in the areas where unwanted hair has been removed or where surface acne has resolved.
The reason HairlessHype combines all three rather than relying on Eflornithine alone is that PCOS-pattern unwanted hair rarely comes in isolation. It usually shows up alongside skin issues — inflammation, uneven tone, surface acne, sometimes scarring from years of hair removal. The combination addresses the whole picture: slow new growth (Eflornithine), weaken what grows (Azelaic Acid), calm the skin and modulate local androgens (Metformin).